Back to Trades
Hamill Laura
DirectorCIK 0001751804
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Hamill Laura, Director, has filed 5 SEC reports (2025–2026), spread across 2 companies, totaling $974.8K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 2 | JAZZ Jazz Pharmaceuticals plc | Hamill Laura | Director | Tax withheld | $411.8K |
| Aug 7 | JAZZ Jazz Pharmaceuticals plc | Hamill Laura | Director | Grant | $0 |
| Jun 15 | FATE FATE THERAPEUTICS INC | Hamill Laura | Insider | Other | $0 |
| Jun 15 | FATE FATE THERAPEUTICS INC | Hamill Laura | Insider | Award | $362.1K |
| Aug 11 | JAZZ Jazz Pharmaceuticals plc | Hamill Laura | Director | Grant | $200.8K |
5 filings